REGENXBIO(RGNX) - 2023 Q1 - Earnings Call Transcript

REGENXBIO Inc. (NASDAQ:RGNX) Q1 2023 Results Conference Call May 3, 2023 4:30 PM ET Company Participants Patrick Christmas - EVP and Chief Legal Officer Ken Mills - CEO Steve Pakola - Chief Medical Officer Vit Vasista - CFO Conference Call Participants Gena Wang - Barclays Dane Leone - Raymond James Gospel Enyindah-Asonye - Morgan Stanley Alec Stranahan - Bank of America Ellie Merle - UBS Lisa Walter - RBC Capital Markets Caroline Palomeque - Berenberg Capital Markets Operator Good day, and thank you for st ...